Ablacon (Menlo Park, Calif.) announced this week that it has secured a $10 million venture debt facility from Western Technology Investment (WTI), accompanied by a $2 million equity investment. The money will help fund the first multicenter randomized clinical trial for Ablamap, Ablacon’s mapping system to guide the treatment of people with atrial fibrillation. “WTI […]
AFib treatment mapping tech dev Ablacon raises $22m
Early-stage cardiovascular tech developer Ablacon said today that it closed a $21.5 million Series A financing round to support its advanced mapping system intended for use in treating atrial fibrillation. Ablacon’s platform uses a novel algorithm and artificial intelligence to analyze and visualize the flow of action potentials within the heart to identify sources and […]
MassDevice Network
@MassDevice
LinkedIn
YouTube